awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36498695-954A5320-7C13-45D7-A56A-70CA48E161F8
Q36498695-954A5320-7C13-45D7-A56A-70CA48E161F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36498695-954A5320-7C13-45D7-A56A-70CA48E161F8
Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes.
P31
Q36498695-954A5320-7C13-45D7-A56A-70CA48E161F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36498695-954A5320-7C13-45D7-A56A-70CA48E161F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6730a49db5828c5189f78e792ee20a1a3d47f568
P31
scholarly article